Some interesting commentary at TechCrunch talks about the rise of founder-led biotech companies, in contrast to the VC-led model that is more common in the US. Since the risk in commercialising biotech is so high, and the capital required is huge, traditionally VC firms have taken the technology off the researchers and installed their own experienced teams to execute the vision. More recently, increasing numbers of biotech firms are led by the researchers themselves, who can learn the process of building a business and taking the product to market themselves.

Read more here: https://techcrunch.com/2019/08/09/biotech-researchers-venture-into-the-wild-to-start-their-own-business/